Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Rev. Inst. Med. Trop. Säo Paulo ; 34(3): 227-32, maio-jun. 1992. tab
Article in English | LILACS | ID: lil-134509

ABSTRACT

Results of a HIV prevalence study conducted in hemophiliacs from Belo Horizonte, Brazil are presented. History of exposure to acellular blood components was determined for the five year period prior to entry in the study, which occurred during 1986 and 1987. Patients with coagulations disorders (hemophilia A = 132, hemophilia B = 16 and coagulation disorders other than hemophilia = 16) were transfused with liquid cryoprecipitate, locally produced, lyophilized cryoprecipitate, imported from Säo Paulo (Brazil) and factor VIII and IX, imported from Rio de Janeiro (Brazil), Europe, and United States. Thirty six (22%) tested HIV seropositive. The univariate and multivariate analysis (logistic model) demonstrated that the risk of HIV infection during the study period was associated with the total units of acellular blood components transfused. In addition, the proportional contribution of the individual components to the total acellular units transfused, namely a increase in factor VIII/IX and lyophilized cryoprecipitate proportions, were found to be associated with HIV seropositivity. This analysis suggest that not only the total amount of units was an important determinant of HIV infection, but that the risk was also associated with the specific component of blood transfused


Subject(s)
Humans , Blood Transfusion/adverse effects , Factor IX/adverse effects , Factor VIII/adverse effects , Hemophilia A/epidemiology , HIV Infections/epidemiology , HIV-1 , Urban Population/statistics & numerical data , Adolescent , Adult , Blood Coagulation Disorders/complications , Blood Coagulation Disorders/epidemiology , Blood Coagulation Disorders/immunology , Blood Coagulation Disorders/therapy , Brazil/epidemiology , Hemophilia A/complications , Hemophilia A/immunology , Hemophilia A/therapy , HIV Antibodies/blood , HIV Infections/etiology
SELECTION OF CITATIONS
SEARCH DETAIL